Ido Weinberg, MD

Vascular MD @MassGeneralNews. @SVM_tweets. The Machine will be God.

[VascularMedicine @VMJ_SVM]

From the current issue: Primary results of the SAVAL randomized trial.
https://t.co/Vm0CQ9JFcX
#CLTI #PeripheralArteryDisease #VascularTwitter

[VascularMedicine @VMJ_SVM]

Online First! @GiacomoBuso and colleagues share humbling data suggesting high rates of symptomatic vascular events in patients with vascular Ehlers-Danlos syndrome despite celiprolol therapy.
#VEDS #VEDSAwarenss

[Ido Weinberg, MD @Angiologist]

@drpete222 @MGHVascular @GParmar_MD @DougDrachmanMD @MGHHeartHealth Peter, thank you :) If you "comment" on the video, I can "reply" and that way other viewers will have this insight.

[Ido Weinberg, MD @Angiologist]

Subclavian artery stenosis - Most patients are asymptomatic. Medical therapy is key. Procedures are for symptoms. Learn more here:

https://t.co/yHn3gmcPgs

@MGHVascular @GParmar_MD @DougDrachmanMD @MGHHeartHealth

[Society for Vascular Medicine | SVM @SVM_tweets]

Did you know there is ~25% added #mortality in patients with #PAD compared to those who don’t?

Join the discussion w/ @GParmar_MD @MGHVascular to learn more about PAD & mortality benefits of low #LDL
https://t.co/0meskVGZT0

@PVDCouncil @lipiddoc @nationallipid @lipid @hmpVDM

[Ido Weinberg, MD @Angiologist]

Avoid this MISTAKE in BLOOD PRESSURE measurement*,**

https://t.co/X7miK1plfD

*Ok. I hate clickbait too. Measure BP in BOTH arms. But still, watch the short clip, LIKE, SHARE, SUBSCRIBE.

**Yup. That's my BP, HR and hair...

@EricSecemskyMD @GParmar_MD @VladLakhter @SVM_tweets

[Society for Vascular Medicine | SVM @SVM_tweets]

It’s not just “go home & walk”
Home based walking exercise does work if done right. Coaching & connecting with patients is also crucial.

It was incredible to have Dr McDermott & @CardioNeela , the lead authors of the article, join the discussion!
@AlexVakiliMD @emoryheart #SVM

[Ido Weinberg, MD @Angiologist]

@bbikdeli @PERTConsortium @GParmar_MD @AndrewDicksMD @SVM_tweets Excellent point. I wonder how various trial data will look if we could see the breakdown of criteria for int-high risk category eligibility.

[Ido Weinberg, MD @Angiologist]

I often don't know what to do with high-sensitivity troponin. Congratulations @bbikdeli et al. for helping confirm our suspicion that we should take it with a grain of salt...

https://t.co/nIsa7m1NVW @PERTConsortium @GParmar_MD

@AndrewDicksMD maybe a @SVM_tweets JC paper? ;)

[Society for Vascular Medicine | SVM @SVM_tweets]

Are you interested in #Cardiology #VascularSurgery #VascularMedicine #IR ?

Don’t miss this amazing learning opportunity for #residents #fellows #APPs !

Registration is now OPEN!
Join #SVM & register today https://t.co/SqgoC4MlQt

@heatherlgornik @adityasharmamd @RKolluriMD

[Society for Vascular Medicine | SVM @SVM_tweets]

In case you missed it!

#GivingTuesday is Today!
Join the movement and support #SVM by donating to this amazing cause -> https://t.co/i2pO5MxMvl

https://t.co/NMC1lDdp9d

@EstherSHKimMD @adityasharmamd @GBarnesMD @RKolluriMD @Angiologist @herbaronowMD @stanhenkin

[Ido Weinberg, MD @Angiologist]

@mmonrealriete Thank you for including me on this paper!

[manuel monreal @mmonrealriete]

Patients with brain cancer have a much higher risk for intracranial bleeding during anticoagulation for VTE

Find it here: https://t.co/CPfPnkLVLV

[Ido Weinberg, MD @Angiologist]

"How do I manage anticoagulation around my procedure?" is one of the more common questions we get asked. So I put together this short explainer:

https://t.co/RiDwEchG2E

@mmonrealriete @adityasharmamd @GParmar_MD @stanhenkin @VladLakhter @AnticoagForum

[manuel monreal @mmonrealriete]

20 years ago, cancer patients with VTE had similar rates of 30-day recurrence or major bleeding during anticoagulation

Nowadays, major bleeds are 2-fold more common than VTE recurrences

Safety is the issue

[Society for Vascular Medicine | SVM @SVM_tweets]

EKOS vs Flowtriever thrombectomy is not always a straightforward decision. Risk of bleeding 🩸 is REAL for both groups although no difference in 30-day readmission, in-hospital death, or ischemic strokes.

https://t.co/hGcRMYpRHn

#VascMedJC #SVM @VMJ_SVM @VladLakhter

[manuel monreal @mmonrealriete]

Among 244 VTE patients with severe renal failure receiving enoxaparin for 6 months, VTE recurrences were less common than major bleeding: 4.1 vs. 13%

But during the first 10 days, fatal PE was 5-fold more common than fatal bleeding: 2.1 vs. 0.4%

Here: https://t.co/GU22F8VAo9

[Society for Vascular Medicine | SVM @SVM_tweets]

Did you know the story behind @EricIsselb96027 ’s license plate?😂
#Aorta #SVM

https://t.co/ctMUBnRSHS

@MGHHeartHealth @GBarnesMD @YogenKanthi @stanhenkin @adityasharmamd @AorticDissectUS @AorticTrauma @AorticDissectUK @AHAScience @ThinkAorta @AorticDissectCT

[Ido Weinberg, MD @Angiologist]

@2Scottish @UR_Med @hopkinsheart Love the socks!

[Ido Weinberg, MD @Angiologist]

Peripheral artery disease (PAD), common and serious, doesn't receive enough attention. Many people suffer leg symptoms with walking, but never receive appropriate care.

I made this video to help #patients understand what to do:

https://t.co/U1402qVCJG

@GParmar_MD @MGHVascular